Caricamento...

The role of bevacizumab in targeted vascular endothelial growth factor therapy for epithelial ovarian cancer: an updated systematic review and meta-analysis

The impact of bevacizumab (an anti-vascular endothelial growth factor therapy) remains uncertain, which has been the focus of studies on the management of epithelial ovarian cancer (EOC). To investigate the efficacy of bevacizumab combinations with different regimens in the treatment of patients wit...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Onco Targets Ther
Autori principali: Ruan, Guanyu, Ye, Lixiang, Liu, Guifen, An, Jian, Sehouli, Jalid, Sun, Pengming
Natura: Artigo
Lingua:Inglês
Pubblicazione: Dove Medical Press 2018
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5788992/
https://ncbi.nlm.nih.gov/pubmed/29416352
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S155581
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !